The burden of central anticholinergic drugs increases pain and cognitive dysfunction. More knowledge about drug-interactions needed-Reference-Cited by-同舟云学术

The burden of central anticholinergic drugs increases pain and cognitive dysfunction. More knowledge about drug-interactions needed

Published:2017-10-01 Issue:1 Volume:17 Page:186-188
ISSN:1877-8860
Container-title:Scandinavian Journal of Pain
language:en
Short-container-title:

Author:

Breivik Harald¹²³

Affiliation:

1. University of Oslo , Faculty of Medicine , OslO , Norway

2. Oslo University Hospital , Department of Pain Management and Research , OslO , Norway

3. Oslo University Hospital , Department of Anaesthesiology , OslO , Norway

Publisher

Walter de Gruyter GmbH

Subject

Anesthesiology and Pain Medicine,Clinical Neurology

Link

https://www.degruyter.com/document/doi/10.1016/j.sjpain.2017.09.022/pdf

Reference16 articles.

1. Rigo FK, Rossato MF, Trevisan G, Prá SD-T, Ineu RP, Duarte MB, de Castro Junior CJ, Ferreira J, Gomez MV. PhKvaToxin isolated from the SpiderVenom induces antinociception by inhibition of cholinesterase activating cholinergic system. Scand J Pain 2017;17:203–10.

2. Rice ASC, Morland R, Huang W, Currie GL, Sena ES, Macleod MR. Transparency in the reporting of in vivo pre-clinical pain research: The relevance and implications of the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines. Scand J Pain 2013;4:58–62.

3. Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr 2015;15:31.

4. Breivik H. The central anticholinergic syndrome and its treatment with Physostigmine [Det sentrale antikolinerge syndrome og dets behandling med fysostigmin]. Tidsskr Nor L^geforen 1975;95:1771–6.

5. Eisenach JC. Muscarinic-mediated analgesia. Life Sci 1999;64:549–54.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target enzymes in oxaliplatin-induced peripheral neuropathy in Swiss mice: A new acetylcholinesterase inhibitor as therapeutic strategy;Chemico-Biological Interactions;2022-01

2. Factors associated with chemotherapy-induced peripheral neuropathy-related reduced taxane dose or premature discontinuation in women with early-stage breast cancer;2021-09-16

3. The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: A review of recent clinical applications;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2019-01